Knowledge Center

Patent / Jan 01, 1973

16.beta.-Methyl-17-hydroxypregna-1,4,9(11)-triene-3,20-dione

Authors:
Source:
GB 1397267

The title compd. (I), useful as intermediate for the manuf. of betametasone, was prepd. Partial ketalization of the trioxo compd. (II), KBH4 redn. of the resulting oxo compd. (III), and subsequent dehydration by MeSO2Cl contg. SO3 gave the epoxypregnene (IV). Grignard reaction of IV with MeMgBr gave the methylhydroxy deriv. (V) and subsequent deketalization the dione (VI), which on 2-step bromination-dehydrobromination or 1-step dehydrogenation by dichlorodicyanobenzoquinone led to I.

Also in the Knowledge Center

Related Content

Devices

ËÄÉ«AV offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more

ASD-HIPROS

ASD-HIPROS, ËÄÉ«AV’s Intelligent Proprietary Screening, is the most advanced and accurate tool to identify Amorphous Solid Dispersion formulations by Spray Drying with maximum performance and stability.

Page
Read more

Customers

Full transparency for your project anywhere at any time.

Page
Read more